| Revenue | NOK 26,7M | +3% |
| EBITDA | NOK 89K | -92% |
| Net profit | NOK -373K | -170% |
| Total assets | NOK 15M | -12% |
| Equity | NOK 10,9M | -3% |
| Employees | 10 | — |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 21 490 | 21 888 | 25 560 | 23 147 | 22 370 | 20 999 | 22 681 | 24 007 | 23 405 | 25 849 | 26 744 |
| Staff expenses | −5 242 | −5 529 | −5 666 | −5 696 | −6 692 | −7 058 | −7 574 | −9 034 | −9 816 | −9 592 | −10 783 |
| EBITDA | 1 487 | 2 134 | 1 450 | 3 693 | 2 496 | 1 847 | 2 089 | 3 593 | 1 053 | 1 052 | 89 |
| Depreciation & amort. | −1 221 | −1 228 | −1 324 | −1 355 | −1 312 | −1 031 | −811 | −451 | −733 | −781 | −832 |
| EBIT | 266 | 906 | 126 | 2 338 | 1 183 | 816 | 1 278 | 3 142 | 320 | 271 | −743 |
| Net financials | 120 | 90 | 48 | 42 | 76 | 111 | 51 | 24 | 64 | 261 | 370 |
| Profit before tax | 386 | 996 | 174 | 2 380 | 1 259 | 927 | 1 329 | 3 165 | 385 | 532 | −373 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 386 | 996 | 174 | 2 380 | 1 259 | 927 | 1 329 | 3 165 | 385 | 532 | −373 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 8 279 | 8 901 | 9 772 | 11 540 | 12 684 | 12 807 | 11 219 | 15 253 | 14 504 | 17 087 | 14 980 |
| Equity | 4 950 | 5 946 | 6 120 | 8 499 | 9 759 | 7 586 | 7 213 | 10 379 | 10 763 | 11 295 | 10 922 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 879 | 2 270 | 3 118 | 2 690 | 2 761 | 5 156 | 4 005 | 4 581 | 3 507 | 5 405 | 3 483 |
| Total debt | 2 879 | 2 270 | 3 118 | 2 690 | 2 761 | 5 156 | 4 005 | 4 581 | 3 507 | 5 405 | 3 483 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BC Chief Executive Officer | Chief Executive Officer | 2008 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Legemiddelservice As | Company | 100.0% | 100.0% | 2023 |
| Person | Role here | Other companies |
|---|---|---|
| Bente Cecilie By Jansen | Chief Executive Officer | 0 companies |
| Nils Gudmund Skjæveland | Board of Directors | 0 companies |
| Sigrun Halvorsen | Board of Directors | 0 companies |
| Kari Struksnes | Board of Directors | 0 companies |
| Leif Rune Skymoen | Chairman | 0 companies |
| Leidulv Solnør | Board of Directors | 0 companies |
| Solrun Elvik | Board of Directors | 0 companies |
| Øyvind Kongstun Arnesen | Chairman | 0 companies |
| Nils Christian Tvedt Karlsen | Board of Directors | 0 companies |